TY  - GEN
AU  - Dewdney,Alice
AU  - Cunningham,David
AU  - Tabernero,Josep
AU  - Capdevila,Jaume
AU  - Glimelius,Bengt
AU  - Cervantes,Andres
AU  - Tait,Diana
AU  - Brown,Gina
AU  - Wotherspoon,Andrew
AU  - Gonzalez de Castro,David
AU  - Chua,Yu Jo
AU  - Wong,Rachel
AU  - Barbachano,Yolanda
AU  - Oates,Jacqueline
AU  - Chau,Ian
TI  - Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
SN  - 1527-7755
PY  - 2012///0712
KW  - Adenocarcinoma
KW  - mortality
KW  - Adult
KW  - Aged
KW  - Analysis of Variance
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Capecitabine
KW  - Cetuximab
KW  - Chemoradiotherapy, Adjuvant
KW  - methods
KW  - Colectomy
KW  - Combined Modality Therapy
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Intestinal Mucosa
KW  - surgery
KW  - Kaplan-Meier Estimate
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Preoperative Care
KW  - Radiotherapy, Adjuvant
KW  - Rectal Neoplasms
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - United Kingdom
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2011.39.6036
ER  -